Reframing Post‐Hepatectomy Liver Failure as a Determinant of Post‐Recurrence Survival in HCC
Journal of Hepato-Biliary-Pancreatic Sciences · 2026-05 · 33 (5) · 343-351
DOI: 10.1002/jhbp.70087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 11.02.2026. Verfasst von Hiroshi Horie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Hepatectomy, Liver Neoplasms, Carcinoma, Hepatocellular, Liver Failure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Post‐hepatectomy liver failure (PHLF) is traditionally considered a transient perioperative complication with limited long‐term consequences, yet its long‐term oncologic implications in hepatocellular carcinoma (HCC) remain unclear.
Methods
Patients undergoing primary hepatectomy for HCC between 2007 and 2018 were analyzed. To ensure reliable assessment of recurrence and post‐recurrence survival, follow‐up was continued through 2023. Associations between PHLF and overall survival (OS), time to recurrence (TTR), and survival after recurrence (SAR) were assessed. Propensity score matching (PSM) analysis controlled for baseline differences.
Results
PHLF ≥ grade B occurred in 59 patients (14.6%). It was significantly associated with worse OS (45.6 vs. 109.7 months, p < 0.001) and SAR (21.5 vs. 55.9 months, p < 0.001), but not TTR. After PSM, these associations persisted. At recurrence, patients with PHLF had worse ALBI scores (−1.92 vs. –2.57, p < 0.001) and lower rates of re‐resection for recurrent disease (6.9% vs. 29.3%, p = 0.026), even after PSM.
Conclusions
PHLF ≥ grade B compromised hepatic reserve at recurrence and limiting curative salvage therapy, leading to impaired SAR and OS. Prevention of PHLF should be prioritized not only to reduce perioperative risk but also to optimize long‐term oncologic outcomes in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
ORCID-Profile: Takahiro Nishio, Takamichi Ishii, Etsuro Hatano
Zitieren
APA
Horie, H., Ogiso, S., Yoh, T., Nishio, T., Fukumitsu, K., Uchida, Y., Ishii, T., & Hatano, E. (2026). Reframing Post‐Hepatectomy Liver Failure as a Determinant of Post‐Recurrence Survival in HCC. Journal of Hepato-Biliary-Pancreatic Sciences, 33(5), 343-351. https://doi.org/10.1002/jhbp.70087
Vancouver
Horie H, Ogiso S, Yoh T, Nishio T, Fukumitsu K, Uchida Y, et al. Reframing Post‐Hepatectomy Liver Failure as a Determinant of Post‐Recurrence Survival in HCC. Journal of Hepato-Biliary-Pancreatic Sciences. 2026;33(5):343-351. doi:10.1002/jhbp.70087
BibTeX
@article{Horie2026,
author = {Horie, Hiroshi and Ogiso, Satoshi and Yoh, Tomoaki and Nishio, Takahiro and Fukumitsu, Ken and Uchida, Yoichiro and Ishii, Takamichi and Hatano, Etsuro},
title = {Reframing Post‐Hepatectomy Liver Failure as a Determinant of Post‐Recurrence Survival in HCC},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2026},
volume = {33},
number = {5},
pages = {343--351},
doi = {10.1002/jhbp.70087}
}
EUVIMED